Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study

PURPOSE: High-dose chemotherapy with autologous stem cell transplantation (ASCT) is considered to be the only curative treatment option for patients with refractory or relapsed diffuse large B-cell lymphoma (DLBCL). Due to toxicity, not all patients are eligible for this treatment leading to differe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epidemiol
Autors principals: Arboe, Bente, Olsen, Maja Halgren, Gørløv, Jette Sønderskov, Duun-Henriksen, Anne Katrine, Dalton, Susanne Oksbjerg, Johansen, Christoffer, de Nully Brown, Peter
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6407517/
https://ncbi.nlm.nih.gov/pubmed/30881137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S178003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars